Jonathan Guo MBBS

Apr 1, 2024 | onlinelibrary.wiley.com | Jonathan Guo |Andrew Hill |Ibukunoluwa King |Jonathan Guo MBBS

1 INTRODUCTION CFTR modulators, and most notably the combination elexacaftor/tezacaftor/ivacaftor (ETI) have revolutionized the treatment of cystic fibrosis (CF), quickly becoming the international standard of care. Yet their prices have been set by the manufacturer, Vertex Pharmaceuticals, at hundreds of thousands of dollars per year.